CareTrust REIT (CTRE) Earnings Date & Reports

Key Takeaways

• CareTrust REIT (CTRE) is scheduled to report second quarter 2026 results on July 30, 2026, after market close.
• Consensus estimates point to GAAP earnings per share of $0.37 and revenue of approximately $122 million to $129 million, according to analyst projections tracked by TipRanks and Finviz.
• The company enters the print with extraordinary momentum, having deployed roughly $1.1 billion in investments year-to-date at a blended stabilized yield of approximately 8.9%.
• Full-year 2026 guidance, raised in May, calls for normalized FFO (Funds From Operations, a key REIT earnings metric) of $2.00 to $2.04 per share, setting a high bar for the second half.
• Analyst sentiment remains overwhelmingly bullish, with 13 analysts rating the stock a consensus Strong Buy and an average 12-month price target near $45, according to S&P Global Market Intelligence.
• Investors will focus closely on any post-quarter investment activity updates, U.K. care home pipeline progress, and whether management adjusts its 2026 outlook.

Earnings Context and Why It Matters

CareTrust REIT's second quarter 2026 earnings report lands at a pivotal moment for the healthcare real estate investment trust. The company has been on an extraordinary acquisition run, deploying $1.1 billion in the first half of the year across skilled nursing facilities, senior housing properties, U.K. care homes, and its emerging SHOP (Senior Housing Operating Portfolio) platform. With the stock trading near its 52-week high and analyst price targets already reflecting elevated expectations, this report will test whether the growth story still has room to surprise. For REIT investors, the key question is whether CareTrust can continue sourcing high-yield deals at scale while maintaining its fortress balance sheet — net debt to annualized normalized run-rate EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) stood at a remarkably low 0.6x at the end of Q1, well below the company's 4.0x to 5.0x target range.

Earnings Expectations

Wall Street analysts tracked by TipRanks and Finviz project CareTrust will report GAAP earnings per share of approximately $0.37 for the second quarter of 2026, up from $0.35 in the same period a year ago. Revenue consensus estimates range from roughly $122 million to $129 million, which would represent a meaningful increase from the $112.5 million reported in Q2 2025. On a normalized FFO basis — the metric most closely followed by REIT investors because it adjusts for non-cash depreciation charges — some analyst estimates point toward roughly $0.51 per share. For context, in Q1 2026 CareTrust delivered normalized FFO of $0.48 per share and GAAP EPS of $0.36, with revenue of $142.8 million. The sequential decline implied by Q2 revenue estimates partly reflects the lumpy timing of acquisition closings, a pattern investors have come to expect from the company's deal-driven model. Importantly, management's full-year guidance — which assumes no new investments beyond those already completed year-to-date — provides a baseline against which any upside will be measured.

AI Screener

Investors tracking earnings events like CareTrust REIT's Q2 report can streamline their research using Tickeron's AI Screener, an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. The platform allows users to scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics, making it possible to identify trade ideas, trending stocks, breakout candidates, and market opportunities far more efficiently than through manual screening alone. For those monitoring the healthcare REIT sector ahead of earnings season, the AI Screener can help surface relevant peer comparisons and potential opportunities in real time.

Market Reaction and Investor Sentiment

Sentiment heading into the Q2 report leans decidedly optimistic. CareTrust shares closed at $42.96 on July 27, hovering near the upper end of their 52-week range and reflecting a market capitalization north of $10 billion. All 13 analysts covering the stock maintain either Buy or Strong Buy ratings, according to S&P Global Market Intelligence, with recent price target increases from firms including Wells Fargo (raised to $53), BMO Capital ($47), KeyBanc ($46), and Bank of America ($49). The stock has historically rewarded investors around earnings — it gained over 4% following the Q1 2026 release in May, when the company raised its full-year guidance and announced the Moody's investment-grade credit rating upgrade. Key risk factors heading into this print include the potential for currency headwinds from the British pound's movement against the U.S. dollar, given CareTrust's growing U.K. care home portfolio, and the persistent cap-rate compression in the competitive SHOP segment that could pressure future acquisition yields.

Forward Outlook and Key Factors to Monitor

Beyond the headline numbers, the Q2 earnings call will offer critical signals about CareTrust's trajectory for the remainder of 2026 and into 2027. The most important variable is the investment pipeline. At the time of the Q1 call in May, management quoted a near-term pipeline of approximately $360 million, heavily weighted toward U.K. care homes and SHOP opportunities. CEO Dave Sedgwick noted that larger portfolio transactions are often excluded from the quoted pipeline, leaving open the possibility of additional deal announcements alongside earnings.

Investors should also monitor any update to the full-year 2026 guidance range. Current normalized FFO guidance of $2.00 to $2.04 per share explicitly assumes no new investments beyond those closed year-to-date — a conservative baseline that, if raised, could serve as a powerful catalyst. On the operational side, rent coverage metrics and occupancy trends in the skilled nursing portfolio remain front and center. At Q1, EBITDAR (Earnings Before Interest, Taxes, Depreciation, Amortization, and Rent) coverage in the stabilized triple-net portfolio stood at 2.25x, while skilled nursing occupancy remained in the low-80% range.

The U.K. expansion represents both an opportunity and a variable to track. With 10 care homes added year-to-date and a pipeline that was "ahead of schedule" as of May, material updates on the pace of U.K. deployment could shape the growth narrative. Meanwhile, the SHOP platform, though still small, is being built with discipline amid intense competition — a segment where management's underwriting rigor will be closely scrutinized. Finally, with the Moody's upgrade now in hand and no debt maturities before 2028, CareTrust's capital allocation choices — including potential inaugural investment-grade bond issuance — could reshape its funding profile in the quarters ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations